<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: coronary artery</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Study examines outcomes of erythropoietin use for heart attack patients undergoing PCI</title>
   	 <description>Intravenous administration of epoetin alfa, a product that stimulates red blood cell production, to patients with heart attack who were undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), did not provide reduction in the size of the heart muscle involved and was associated with higher rates of adverse cardiovascular events, according to a study in the May 11 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2011-05-outcomes-erythropoietin-heart-patients-pci.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 10 May 2011 16:25:29 EST</pubDate>
	 <guid isPermaLink="false">news224263508</guid>
	 
</item>
<item>
     <title>Lessons from major heart trial need implementation</title>
   	 <description>A NewYork-Presbyterian Hospital/Weill Cornell Medical Center review of almost 500,000 cardiac cases nationally shows that the clinically indicated medical therapy reported in a widely publicized study was lost in translation to real-world heart care after its publication.</description>
     <link>http://medicalxpress.com/news/2011-05-patients-seldom-optimal-medical-therapy.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 10 May 2011 16:23:55 EST</pubDate>
	 <guid isPermaLink="false">news224263398</guid>
	 
</item>


</channel>
</rss>
